Nanosystem composed with MSNs, gadolinium, liposome and cytotoxic peptides for tumor theranostics.

A dual-functional delivery system, based on mesoporous silica nanoparticles (MSNs) with the integration of Magnetic Resonance (MR) imaging and therapeutic peptide delivery, is reported in this paper. A lipid bilayer is attached onto the surface of the nanoparticles, following the doping of Gadolinium (Gd), a paramagnetic lanthanide ion. The liposome-coated GdMSNs exhibit improved colloidal stability, better biocompatibility and more efficient cellular uptake. The Gd renders the nano carrier a potential T1 contrast agent, confirmed by the MR imaging. A pro-apoptotic peptide, KLA (HGGKLAKLAKKLAKLAK), is encapsulated into the GdMSNs-LP and enters into the cells successfully to induce mitochondrial swelling and apoptosis, while it is nontoxic outside the cells. The synthesis procedure is convenient and free of toxic organic reagents. The nanosystem we construct may contribute to a promising theranostic platform for therapeutic peptide delivery in cancer treatment.

[1]  Ick Chan Kwon,et al.  New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy , 2009 .

[2]  D. Losic,et al.  Polymeric micelles for multidrug delivery and combination therapy. , 2013, Chemistry.

[3]  Yongmei Jia,et al.  Dual stimuli-responsive nano-vehicles for controlled drug delivery: mesoporous silica nanoparticles end-capped with natural chitosan. , 2014, Chemical communications.

[4]  A. Adjei,et al.  Targeting Apoptosis Pathways in Cancer Therapy , 2005, CA: a cancer journal for clinicians.

[5]  V. S. Lin,et al.  Gatekeeping layer effect: a poly(lactic acid)-coated mesoporous silica nanosphere-based fluorescence probe for detection of amino-containing neurotransmitters. , 2004, Journal of the American Chemical Society.

[6]  A. Caminade,et al.  Dendrimers for drug delivery. , 2014, Journal of materials chemistry. B.

[7]  Yikun Gao,et al.  Facile synthesis of the lipid bilayer coated mesoporous silica nanocomposites and their application in drug delivery , 2016 .

[8]  Juan L. Vivero-Escoto,et al.  Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. , 2009, Journal of the American Chemical Society.

[9]  V. S. Lin,et al.  Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP. , 2009, Journal of the American Chemical Society.

[10]  Wenjun Meng,et al.  Hollow Mesoporous Silica/Poly(l-lysine) Particles for Codelivery of Drug and Gene with Enzyme-Triggered Release Property , 2011 .

[11]  Jian Liu,et al.  Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. , 2011, Nanoscale.

[12]  Erkki Ruoslahti,et al.  Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.

[13]  Shiyong Liu,et al.  Fluorescent pH-sensing organic/inorganic hybrid mesoporous silica nanoparticles with tunable redox-responsive release capability. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[14]  Peter Csermely,et al.  Response to Associate Editor , 2016 .

[15]  Jin Wu,et al.  The photoluminescence, drug delivery and imaging properties of multifunctional Eu3+/Gd3+ dual-doped hydroxyapatite nanorods. , 2011, Biomaterials.

[16]  John Calvin Reed,et al.  Apoptosis-based therapies , 2002, Nature Reviews Drug Discovery.

[17]  Meiying Wang,et al.  Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice , 2015, ACS nano.

[18]  M. Sioud,et al.  Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide. , 2012, Biochemical pharmacology.

[19]  M. Wong Chi Man,et al.  Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery. , 2015, Chemistry.

[20]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[21]  G. Lu,et al.  A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles , 2012 .

[22]  Robert Langer,et al.  Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.

[23]  F. Xiao,et al.  pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery , 2005 .

[24]  D. Shi.  Integrated Multifunctional Nanosystems for Medical Diagnosis and Treatment , 2009 .

[25]  W. Long,et al.  Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer , 2015, Scientific Reports.

[26]  Cheuk Y. Tang,et al.  Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. , 2008, Nano letters.

[27]  Xian‐Zheng Zhang,et al.  A surface charge-switchable and folate modified system for co-delivery of proapoptosis peptide and p53 plasmid in cancer therapy. , 2016, Biomaterials.

[28]  Brian P. Timko,et al.  Remotely Triggerable Drug Delivery Systems , 2010, Advanced materials.

[29]  Tao Wu,et al.  Tunable redox-responsive hybrid nanogated ensembles. , 2008, Journal of the American Chemical Society.